Medicare Enrolled

Dr. Vikram Atit, MD

Neurology · Holiday, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1011 US HWY 19, Holiday, FL 34691
7279374600
In practice since 2006 (20 years)
NPI: 1871560904 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Atit from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atit? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Atit

Dr. Vikram Atit is a neurology in Holiday, FL, with 20 years in practice. Based on federal Medicare data, Dr. Atit performed 1,352 Medicare services across 1,184 unique beneficiaries.

Between the years covered by Open Payments, Dr. Atit received a total of $79,965 from 87 pharmaceutical and/or device companies across 2187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Atit is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 24% volume in FL$ $79,965 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,352
Medicare services
Top 24% in FL for neurology
1,184
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~68 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)208$93$255
Initial hospital admission, high complexity205$131$405
Hospital follow-up visit, high complexity190$92$240
Office visit, established patient, complex (40-54 min)151$130$365
New patient office visit, complex (60-74 min)90$155$445
Initial hospital admission, moderate complexity71$92$280
Needle measurement of electrical activity in arm or leg muscles, complete study67$75$199
Office visit, established patient (20-29 min)59$67$180
EEG, extended monitoring55$318$930
Hospital follow-up visit, moderate complexity53$61$159
Measurement of brain wave activity (eeg), awake and drowsy49$43$115
Evaluation of neuropsychological test, first hour41$101$270
Nerve conduction, 9-10 studies36$163$470
New patient office visit (45-59 min)30$121$335
Critical care, first 30-74 min20$162$565
Nerve conduction, 11-12 studies16$191$545
Nerve conduction, 13 or more studies11$220$635
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$79,965
Total received (2018-2024)
Avg $11,424/year across 7 years
Top 6% in FL for neurology
87
Companies
2,187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42,030 (52.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35,114 (43.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,821 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,108
2023
$5,095
2022
$13,098
2021
$19,870
2020
$12,390
2019
$7,921
2018
$18,482

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$10,218
Allergan, Inc.
$9,434
AbbVie Inc.
$8,313
Sunovion Pharmaceuticals Inc.
$8,291
ABBVIE INC.
$4,941
SK Life Science, Inc.
$3,554
Biohaven Pharmaceutical Holding Company Ltd.
$2,776
Teva Pharmaceuticals USA, Inc.
$2,206
Novartis Pharmaceuticals Corporation
$2,152
UCB, Inc.
$2,091
Amgen Inc.
$1,975
Neurocrine Biosciences, Inc.
$1,844
Alexion Pharmaceuticals, Inc.
$1,404
EMD Serono, Inc.
$1,093
Eisai Inc.
$1,054
Lilly USA, LLC
$1,040
CSL Behring
$1,014
GENZYME CORPORATION
$948
Avanir Pharmaceuticals, Inc.
$904
Amneal Pharmaceuticals LLC
$881
Biogen, Inc.
$863
Adamas Pharmaceuticals, Inc.
$840
Celgene Corporation
$840
Octapharma USA, Inc.
$729
Acorda Therapeutics, Inc
$727
Janssen Pharmaceuticals, Inc
$684
Biohaven Pharmaceuticals, Inc.
$671
ACADIA Pharmaceuticals Inc
$620
Allergan Inc.
$545
PFIZER INC.
$533
JAZZ PHARMACEUTICALS INC.
$488
Kyowa Kirin, Inc.
$444
E.R. Squibb & Sons, L.L.C.
$417
Lundbeck LLC
$415
Genentech USA, Inc.
$394
Otsuka America Pharmaceutical, Inc.
$367
IMPEL PHARMACEUTICALS INC.
$363
EISAI INC.
$320
MDD US Operations, LLC
$249
US WorldMeds, LLC
$183
Jazz Pharmaceuticals Inc.
$180
Mallinckrodt Hospital Products Inc.
$167
ARGENX US, INC.
$160
Sumitomo Pharma America, Inc.
$145
Bayer HealthCare Pharmaceuticals Inc.
$136
Upsher-Smith Laboratories LLC
$123
Impax Laboratories, Inc.
$121
Zyla Life Sciences
$117
Azurity Pharmaceuticals, Inc.
$111
Corium, LLC
$108
MITSUBISHI TANABE PHARMA AMERICA, INC.
$107
SANOFI-AVENTIS U.S. LLC
$102
Nevro Corp.
$102
Horizon Therapeutics plc
$100
GE HEALTHCARE
$92
UPSHER-SMITH LABORATORIES LLC
$92
Greenwich Biosciences, Inc.
$80
ARBOR PHARMACEUTICALS, INC.
$69
Neurelis, Inc.
$66
CATALYST PHARMACEUTICALS, INC.
$65
Avion Pharmaceuticals
$57
Zyla Life Sciences, Inc.
$57
PORTOLA PHARMACEUTICALS, INC.
$56
LivaNova USA, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$46
TG Therapeutics, Inc.
$45
Merck Sharp & Dohme Corporation
$44
Scilex Pharmaceuticals Inc.
$43
Banner Life Sciences, LLC
$43
Mallinckrodt LLC
$39
Xeris Pharmaceuticals, Inc.
$37
NATUS MEDICAL INCORPORATED
$37
Harmony Biosciences LLC
$36
Ceribell, Inc.
$35
Arbor Pharmaceuticals, Inc.
$33
Boston Scientific Corporation
$32
Grifols USA, LLC
$31
AstraZeneca Pharmaceuticals LP
$27
Catalyst Pharmaceuticals, Inc.
$26
TG THERAPEUTICS, INC.
$23
SI-BONE, INC.
$22
Medtronic USA, Inc.
$18
Bausch Health US, LLC
$14
Merck Sharp & Dohme LLC
$13
Exeltis, USA Inc.
$13
BANNER LIFE SCIENCES, LLC
$13
Life Molecular Imaging Ltd
$11
Top 3 companies account for 35.0% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APLENZIN · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · CREXONT · CUTAQUIG · Cenobamate · Ceribell Rapid Response EEG · DISEASE STATE · DUOPA · Dayvigo · Dhivy · ELIQUIS · EMGALITY · EPIDIOLEX · EVUSHELD · Epidiolex · Erivedge · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GAMMAGARD LIQUID · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KYNMOBI · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rystiggo · SKYCLARYS · SOLIRIS · SPRIX · SUNOSI · Senza · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XCOPRI · XYREM · XYWAV · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZORVOLEX · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in FL.

Equivalent to $5,915 per 100 Medicare services performed
Looking for a neurology in Holiday?
Compare neurologys in the Holiday area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
142
Per 100K population
24.1
County median income
$67,384
Nearest hospital
ADVENTHEALTH NORTH PINELLAS
3.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Atit is a clinical cardiology specialist, with above-average Medicare volume (top 24% in FL), and high industry engagement (speaking/promotional, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Atit experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Atit performed 208 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atit receive payments from pharmaceutical companies?
Yes. Dr. Atit received a total of $79,965 from 87 companies across 2,187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atit's costs compare to other neurologys in Holiday?
Dr. Atit's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atit) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →